Analyze Diet
The Cornell veterinarian1984; 74(3); 282-297;

Vascular pathology in phenylbutazone intoxicated horses.

Abstract: Three mature Thoroughbred geldings were given 13.63 mg phenylbutazone/Kg bodyweight intravenously for 3 days and repeated in one horse 4 days later. After 4, 7 and 10 days (double treatment), degeneration of the wall of small veins occurred in all horses. The veins were dilated and/or showed hyalin degeneration. The phlebopathy was interpreted to be paramount in phenylbutazone intoxication. All other manifestations, including erythro- and leukodiapedesis, submucosal edema and ulceration of the gastrointestinal mucosa, phlebothrombosis and significant changes in the hemogram and serum chemistry, were considered secondary to the vein lesions.
Publication Date: 1984-07-01 PubMed ID: 6734211
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't
  • Research Support
  • U.S. Gov't
  • P.H.S.

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research study involves the examination of the vascular pathologies in three Thoroughbred geldings due to an overdose of phenylbutazone, finding that the drug caused degeneration in the small veins and other adverse effects.

Research Methodology

  • The researchers used three mature Thoroughbred geldings for the study. These horses were administered with 13.63mg phenylbutazone per Kg of their body weight intravenously for a span of 3 days. This treatment was again repeated for one of the horses after 4 days.
  • After 4, 7, and 10 days, various observations were made to study the effects of such high dosage of phenylbutazone on the horses. The effects were compared in horses who received the treatment once and the ones who got a double dose.

Findings and Interpretation

  • The researchers found the small veins in all horses had yearned a state of degeneration due to the high dosage of phenylbutazone. The veins were either dilated or showed hyalin degeneration.
  • This phlebopathy, a venous disorder, was considered as the primary side effect of phenylbutazone overdose. All the other observed side effects such as erythro- and leukodiapedesis (passage of blood cells through the intact walls of capillaries), submucosal edema (swelling beneath the mucous membrane), ulceration of the gastrointestinal mucosa, phlebothrombosis (venous thromboembolism), and significant changes in the hemogram and serum chemistry, were considered secondary.
  • Thus, the researchers interpreted the vein lesions as the most significant pathological factor in phenylbutazone overdose.

Cite This Article

APA
Meschter CL, Maylin GA, Krook L. (1984). Vascular pathology in phenylbutazone intoxicated horses. Cornell Vet, 74(3), 282-297.

Publication

ISSN: 0010-8901
NlmUniqueID: 0074245
Country: United States
Language: English
Volume: 74
Issue: 3
Pages: 282-297

Researcher Affiliations

Meschter, C L
    Maylin, G A
      Krook, L

        MeSH Terms

        • Animals
        • Horse Diseases / chemically induced
        • Horse Diseases / pathology
        • Horses
        • Male
        • Phenylbutazone / poisoning
        • Vascular Diseases / chemically induced
        • Vascular Diseases / pathology
        • Vascular Diseases / veterinary
        • Veins / drug effects
        • Veins / pathology

        Grant Funding

        • 5 T32 E 507 105 / PHS HHS

        Citations

        This article has been cited 2 times.
        1. Semrad SD, Dubielzig R. Effect of repeated administration of tirilazad mesylate on healthy and endotoxemic calves: a pilot study. Can J Vet Res 1994 Jan;58(1):67-70.
          pubmed: 8143257
        2. Powell CJ, Grasso P, Ioannides C, Wilson J, Bridges JW. Haloalkylamine-induced renal papillary necrosis: a histopathological study of structure-activity relationships. Int J Exp Pathol 1991 Dec;72(6):631-46.
          pubmed: 1768609